Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Boman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|January 1, 1996
Liposomal doxorubicinP G Tardi, N L Boman, P R Cullis
Biochimica Et Biophysica Acta|November 7, 1993
Optimization of the retention properties of vincristine in liposomal systemsN L Boman, L D Mayer, P R Cullis
Cancer Chemotherapy and Pharmacology|January 1, 1996
Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomesN L Boman, V A Tron, M B Bally, et al.
British Journal of Cancer|March 1, 1995
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumoursL D Mayer, D Masin, R Nayar, et al.
Cancer Research|June 1, 1994
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumorsN L Boman, D Masin, L D Mayer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemiaL D Mayer, R Nayar, R L Thies, et al.
Antimicrobial Agents and Chemotherapy|February 4, 1998
Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulationM S Webb, N L Boman, D J Wiseman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|January 1, 1996
Liposomal doxorubicinP G Tardi, N L Boman, P R Cullis
Biochimica Et Biophysica Acta|November 7, 1993
Optimization of the retention properties of vincristine in liposomal systemsN L Boman, L D Mayer, P R Cullis
Cancer Chemotherapy and Pharmacology|January 1, 1996
Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomesN L Boman, V A Tron, M B Bally, et al.
British Journal of Cancer|March 1, 1995
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumoursL D Mayer, D Masin, R Nayar, et al.
Cancer Research|June 1, 1994
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumorsN L Boman, D Masin, L D Mayer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemiaL D Mayer, R Nayar, R L Thies, et al.
Antimicrobial Agents and Chemotherapy|February 4, 1998
Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulationM S Webb, N L Boman, D J Wiseman, et al.
Pageof 1